Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zeki Kocaata"'
Autor:
Shahina Begum, Eliazar Sabater Cabrera, Oscar Herrera Restrepo, Cindy Burman, Woo-Yun Sohn, Elise Kuylen, Hiral Shah, Zeki Kocaata
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 9, Pp 2001-2015 (2024)
Abstract Introduction Invasive meningococcal disease (IMD) is a severe and life-threatening disease. In the United States (US), vaccine coverage with MenACWY and MenB meningococcal vaccines is suboptimal among adolescents/young adults aged 16–23 ye
Externí odkaz:
https://doaj.org/article/685e8d5d9eb04e7ca817069ca3e6b369
Autor:
Shahina Begum, Oscar Herrera-Restrepo, Catherine Rolland, Sneha Purushotham, Anar Andani, Hiral Shah, Zeki Kocaata
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Vaccination remains the most effective strategy to prevent invasive meningococcal disease (IMD), with MenACWY, MenB and MenABCWY recommended for adolescents/young adults in the United States (US). However, vaccination coverage remains suboptimal, whi
Externí odkaz:
https://doaj.org/article/0e8842964ca9405da11787b62d21403e
Autor:
Federico Martinón-Torres, Ángel Gil de Miguel, Jesús Ruiz-Contreras, Laura A. Vallejo-Aparicio, Andrea García, María C. Gonzalez-Inchausti, Eduardo de Gomensoro, Zeki Kocaata, Clara Gabás-Rivera, Marta Comellas, Miriam Prades, Luis Lizán
Publikováno v:
Infectious Diseases and Therapy. 12:157-175
Immunization is the most effective strategy for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB); however, parents need to weigh the risk-benefit and financial impact of immunizing their children ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6c6e4f218d34ee0ad25a1327d754a34
https://doi.org/10.1007/s40121-022-00708-7
https://doi.org/10.1007/s40121-022-00708-7
Autor:
Fränce Hardtstock, Zeki Kocaata, Thomas Wilke, Axel Dittmar, Marco Ghiani, Vasily Belozeroff, David J. Harrison, Ulf Maywald, Hans Tesch
Publikováno v:
The European Journal of Health Economics
Background This study analyzes the impact of skeletal-related events (SRE) on healthcare resource utilization (HCRU) and costs incurred by patients with bone metastases (BM) from solid tumors (ST), who are therapy-naïve to bone targeting agents (BTA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd962308effdb9ae4d76866753c5c6e
http://europepmc.org/articles/PMC7881971
http://europepmc.org/articles/PMC7881971
Publikováno v:
PharmacoEconomics - open. 6(4)
This study aimed to analyze the healthcare resource use (HCRU) and associated costs of multiple myeloma (MM) using German claims data.Anonymized claims data from one of the largest sickness funds in Germany were analyzed. Costs and HCRU were calculat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac74f34923ff68104bb66f791f650810
https://pubmed.ncbi.nlm.nih.gov/35750956
https://pubmed.ncbi.nlm.nih.gov/35750956
Publikováno v:
Patient Preference and Adherence. 14:613-624
Background Current antiviral therapies for chronic hepatitis B (CHB) rarely achieve functional cure, thus often requiring lifelong therapy. A therapy achieving functional cure in a significant percentage of patients could change the treatment landsca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd4bd26adcdc80a636f79942f5b2ba95
https://doi.org/10.2147/ppa.s238833
https://doi.org/10.2147/ppa.s238833
Autor:
Fraence Hardtstock, Zaza Katsarava, Thomas Wilke, Zeki Kocaata, Tim Kirchmann, Ulf Maywald, Alice Eberhardt
BackgroundMigraine is still an area of significant unmet therapeutic needs with a high degree of underdiagnosis and undertreatment of patients. This retrospective claims data analysis aimed to describe the acute and prophylactic treatment patterns of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d402ed6318bc3385320aa101d61ce5e
https://doi.org/10.21203/rs.3.rs-57269/v1
https://doi.org/10.21203/rs.3.rs-57269/v1
Publikováno v:
Patient preference and adherence
Background Current antiviral therapies for chronic hepatitis B (CHB) rarely achieve functional cure, thus often requiring lifelong therapy. A therapy achieving functional cure in a significant percentage of patients could change the treatment landsca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::41bc1abc42cc64b5b2785df69f8d9290
https://pubmed.ncbi.nlm.nih.gov/32256052
https://pubmed.ncbi.nlm.nih.gov/32256052